We serve Chemical Name:4′-(Dimethylamino)benzylidene-4-nitroaniline CAS:896-05-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4′-(Dimethylamino)benzylidene-4-nitroaniline
CAS.NO:896-05-9
Synonyms:MFCD00086550;4′-(dimethylamino)benzylidene-4-nitroaniline
Molecular Formula:C15H15N3O2
Molecular Weight:269.29900
HS Code:2925290090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:451.8ºC at 760 mmHg
Density:1.14g/cm3
Index of Refraction:1.582
PSA:61.42000
Exact Mass:269.11600
LogP:3.93460
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like MFCD00086550 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4′-(dimethylamino)benzylidene-4-nitroaniline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,MFCD00086550 Use and application,4′-(dimethylamino)benzylidene-4-nitroaniline technical grade,usp/ep/jp grade.
Related News: This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 4′-(Dimethylamino)benzylidene-4-nitroaniline manufacturer The fine chemical industry includes fine chemicals and special chemicals. Fine chemical products have the characteristics of a small amount of production, relatively specific application fields, and long and complex industrial chains. They are mainly used in medicine, pesticides, dyes, liquid crystals and other fields. 4′-(Dimethylamino)benzylidene-4-nitroaniline supplier This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 4′-(Dimethylamino)benzylidene-4-nitroaniline vendor This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 4′-(Dimethylamino)benzylidene-4-nitroaniline factory Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.
